Molecular Diagnostics of Bacterial Infections and Antibiotic Resistance in Blood Samples and Rectal Swabs Using Real Time PCR-ARES PCR Methods

Launched by IRCCS SACRO CUORE DON CALABRIA DI NEGRAR · Mar 6, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at ways to identify specific drug-resistant bacteria in blood and rectal samples using a method called real-time PCR. The goal is to see how well this testing method can find certain harmful bacteria that can make infections harder to treat. The samples being studied are already collected and stored at a biobank, so participants don’t need to undergo any additional procedures or treatments.

To be part of this trial, participants must have had blood tests and rectal swabs done at a specific hospital to check for multi-drug resistant bacteria. They also need to have given permission for their samples to be used for research. This study is open to all genders and ages, as long as the necessary criteria are met. Participants can expect their stored samples to be analyzed, contributing to important research that could help improve how these infections are diagnosed in the future.

Gender

ALL

Eligibility criteria

• Inclusion criteria:
• • Samples of patients for whom blood culture and Multi Drug Resistant (MDR) surveillance tests were carried out in rectal swabs at the IRCCS Sacro Cuore Don Calabria Hospital
• • Samples for which the Information and consent to the conservation of biological samples for research purposes at the Tropica Biobank has been signed
• Exclusion criteria:
• • Absence of data relating to positivity or negativity to the germs of interest
• • Absence of stored residual material
• • Absence of information and consent to the conservation of biological samples for signed research purposes